Ro CEO on the next phase of the Ozempic boom

Zach Reitano discusses scaling GLP-1 care, tackling backlash, and what comes after weight-loss drugs go mainstream. Since first appearing on the Masters of Scale podcast at the height of the Ozempic-Wegovy-Zepbound boom, Zach Reitano, CEO of Ro, has helped scale his company into a leading provider of branded GLP-1s-grabbing headlines with a 2026 Super Bowl ad featuring tennis champion Serena Williams and landing a major partnership with Novo Nordisk for the pill version of Wegovy. Now Reitano ha...